Cargando…

Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015

BACKGROUND: The widespread use of antiretroviral therapy (ART) has led to considerable concerns about the prevalence of transmitted drug resistance (TDR). Sexual contact, particularly men who have sex with men (MSM) was the most prevalent form of HIV transmission in Shijiazhuang. Hence, we conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianfeng, Liu, Xiaosong, Li, Feng, Zhou, Hong, Li, Jiefang, Wang, Yingying, Liu, Lihua, Liu, Shujun, Feng, Yi, Wang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988301/
https://www.ncbi.nlm.nih.gov/pubmed/29870534
http://dx.doi.org/10.1371/journal.pone.0198005
_version_ 1783329258622418944
author Wang, Xianfeng
Liu, Xiaosong
Li, Feng
Zhou, Hong
Li, Jiefang
Wang, Yingying
Liu, Lihua
Liu, Shujun
Feng, Yi
Wang, Ning
author_facet Wang, Xianfeng
Liu, Xiaosong
Li, Feng
Zhou, Hong
Li, Jiefang
Wang, Yingying
Liu, Lihua
Liu, Shujun
Feng, Yi
Wang, Ning
author_sort Wang, Xianfeng
collection PubMed
description BACKGROUND: The widespread use of antiretroviral therapy (ART) has led to considerable concerns about the prevalence of transmitted drug resistance (TDR). Sexual contact, particularly men who have sex with men (MSM) was the most prevalent form of HIV transmission in Shijiazhuang. Hence, we conducted an epidemiological surveillance study on TDR among newly diagnosed individuals who infected-HIV through sexual contact in from 2014–2015. METHODS: Genotypic resistance mutations were defined using the WHO-2009 surveillance list. Potential impact on antiretroviral drug was predicted according to the Stanford HIV db program version 7.0. The role of transmission clusters in drug resistant strains was evaluated by phylogenetic and network analyses. RESULTS: In this study, 589 individuals were recruited and 542 samples were amplified and sequenced successfully. The over prevalence of TDR was 6.1%: 1.8% to nucleoside reverse transcriptase inhibitors (NRTIs), 2.0% to non- NRTIs (NNRTIs) and 2.4% to protease inhibitors (PIs), respectively. We did not find significant differences in the TDR prevalence by demographic and clinical characteristics (p > 0.05). Using network and phylogenetic analysis, almost 60.0% sequences were clustered together. Of these clusters, 2 included at least two individuals carrying the same resistance mutation, accounting for 21.2% (7/33) individuals with TDR. No significant difference was observed in the clustering rate between the individuals with and without TDR. CONCLUSIONS: We obtained a moderate level TDR rate in studied region. These findings enhance our understanding of HIV-1 drug resistance prevalence in Shijiazhuang, and may be helpful for the comprehensive prevention and control of HIV-1.
format Online
Article
Text
id pubmed-5988301
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-59883012018-06-16 Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015 Wang, Xianfeng Liu, Xiaosong Li, Feng Zhou, Hong Li, Jiefang Wang, Yingying Liu, Lihua Liu, Shujun Feng, Yi Wang, Ning PLoS One Research Article BACKGROUND: The widespread use of antiretroviral therapy (ART) has led to considerable concerns about the prevalence of transmitted drug resistance (TDR). Sexual contact, particularly men who have sex with men (MSM) was the most prevalent form of HIV transmission in Shijiazhuang. Hence, we conducted an epidemiological surveillance study on TDR among newly diagnosed individuals who infected-HIV through sexual contact in from 2014–2015. METHODS: Genotypic resistance mutations were defined using the WHO-2009 surveillance list. Potential impact on antiretroviral drug was predicted according to the Stanford HIV db program version 7.0. The role of transmission clusters in drug resistant strains was evaluated by phylogenetic and network analyses. RESULTS: In this study, 589 individuals were recruited and 542 samples were amplified and sequenced successfully. The over prevalence of TDR was 6.1%: 1.8% to nucleoside reverse transcriptase inhibitors (NRTIs), 2.0% to non- NRTIs (NNRTIs) and 2.4% to protease inhibitors (PIs), respectively. We did not find significant differences in the TDR prevalence by demographic and clinical characteristics (p > 0.05). Using network and phylogenetic analysis, almost 60.0% sequences were clustered together. Of these clusters, 2 included at least two individuals carrying the same resistance mutation, accounting for 21.2% (7/33) individuals with TDR. No significant difference was observed in the clustering rate between the individuals with and without TDR. CONCLUSIONS: We obtained a moderate level TDR rate in studied region. These findings enhance our understanding of HIV-1 drug resistance prevalence in Shijiazhuang, and may be helpful for the comprehensive prevention and control of HIV-1. Public Library of Science 2018-06-05 /pmc/articles/PMC5988301/ /pubmed/29870534 http://dx.doi.org/10.1371/journal.pone.0198005 Text en © 2018 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Wang, Xianfeng
Liu, Xiaosong
Li, Feng
Zhou, Hong
Li, Jiefang
Wang, Yingying
Liu, Lihua
Liu, Shujun
Feng, Yi
Wang, Ning
Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
title Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
title_full Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
title_fullStr Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
title_full_unstemmed Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
title_short Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014–2015
title_sort epidemiological surveillance of hiv-1 transmitted drug resistance among newly diagnosed individuals in shijiazhuang, northern china, 2014–2015
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988301/
https://www.ncbi.nlm.nih.gov/pubmed/29870534
http://dx.doi.org/10.1371/journal.pone.0198005
work_keys_str_mv AT wangxianfeng epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT liuxiaosong epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT lifeng epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT zhouhong epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT lijiefang epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT wangyingying epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT liulihua epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT liushujun epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT fengyi epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015
AT wangning epidemiologicalsurveillanceofhiv1transmitteddrugresistanceamongnewlydiagnosedindividualsinshijiazhuangnorthernchina20142015